Scribd
Upload
49 views3 pages

Liraglutide For Managing Obesity in People Aged 12 To 17 Years Terminated Appraisal PDF 82611323369413

The document summarizes guidance from NICE regarding the use of liraglutide for managing obesity in people aged 12 to 17 years. NICE is unable to make a recommendation about using liraglutide due to the manufacturer not providing an evidence submission. NICE will review if the manufacturer decides to submit evidence in the future.

Uploaded by

Yilianeth Mena Daza
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
49 views3 pages

Liraglutide For Managing Obesity in People Aged 12 To 17 Years Terminated Appraisal PDF 82611323369413

The document summarizes guidance from NICE regarding the use of liraglutide for managing obesity in people aged 12 to 17 years. NICE is unable to make a recommendation about using liraglutide due to the manufacturer not providing an evidence submission. NICE will review if the manufacturer decides to submit evidence in the future.

Uploaded by

Yilianeth Mena Daza
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 3

Liraglutide for managing

obesity in people aged 12 to


17 years (terminated
appraisal)

Technology appraisal guidance


Published: 1 December 2021
www.nice.org.uk/guidance/ta749

© NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-


rights).
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal) (TA749)

Contents
Advice ........................................................................................................................................................................ 3

Information ........................................................................................................................................................................... 3

© NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- Page 2 of
conditions#notice-of-rights). 3
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal) (TA749)

Advice
NICE is unable to make a recommendation about the use in the NHS of liraglutide for managing
obesity in people aged 12 to 17 years. This is because Novo Nordisk does not intend to provide an
evidence submission for the appraisal. Novo Nordisk considers that there is not enough evidence to
provide an evidence submission for this appraisal.

Information
If NHS organisations wish to consider liraglutide for this indication, they should follow the advice
on rational local decision making in the NHS Constitution for England and the NHS Commissioning
Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012.
This outlines the approach that should be taken when there is no NICE guidance.

NICE will review the position if the company decides that it wants to make an evidence submission.

ISBN: 978-1-4731-4361-6

Accreditation

© NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- Page 3 of
conditions#notice-of-rights). 3

You might also like